EW240920C95000
- 0.05
- 0.000.00%
Edwards Lifesciences Newsroom
10 Health Care Stocks With Whale Alerts In Today's Session
Edwards Lifesciences Downgraded at Jefferies on Lower TAVR Growth
Jefferies Maintains Edwards Lifesciences(EW.US) With Hold Rating, Maintains Target Price $70
Jefferies analyst Matthew Taylor maintains $Edwards Lifesciences(EW.US)$ with a hold rating, and maintains the target price at $70.According to TipRanks data, the analyst has a success rate of 58.2%
Edwards Lifesciences Analyst Ratings
Wells Fargo Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $80
Wells Fargo analyst Larry Biegelsen maintains $Edwards Lifesciences(EW.US)$ with a buy rating, and maintains the target price at $80.According to TipRanks data, the analyst has a success rate of 64.2%
Jefferies Downgrades Edwards Lifesciences(EW.US) to Hold Rating, Cuts Target Price to $70
Jefferies analyst Matthew Taylor downgrades $Edwards Lifesciences(EW.US)$ to a hold rating, and adjusts the target price from $102 to $70.According to TipRanks data, the analyst has a success rate
Jefferies Downgrades Edwards Lifesciences to Hold From Buy, Adjusts Price Target to $70 From $85
Edwards Lifesciences: Hold Rating Amid TAVR Sector Challenges and Growth Constraints
Express News | Edwards Lifesciences Corp Shares Hit Session Low, Falling Sharply in Afternoon Volume Pickup, Last Down 1.7% at $68.11
Edwards Launches SAPIEN 3 With Alterra Prestent in Europe for Transcatheter Pulmonic Valve Implantation
Watching Edwards Lifesciences; Traders Circulate Unconfirmed M&A Blog Comments Suggesting The Co Is Engaged In Takeover Chatter
BofA Securities Downgrades Edwards Lifesciences(EW.US) to Hold Rating, Cuts Target Price to $75
BofA Securities analyst Travis Steed downgrades $Edwards Lifesciences(EW.US)$ to a hold rating, and adjusts the target price from $105 to $75.According to TipRanks data, the analyst has a success
Unusual Options Activity: ETSY, SWKS and Others Attract Market Bets, ETSY V/OI Ratio Reaches 119.8
EST Sep 13th Morning Delivery - In the last two hours of trading, 8 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Truist Financial Downgrades Edwards Lifesciences(EW.US) to Hold Rating
Truist Financial analyst Richard Newitter downgrades $Edwards Lifesciences(EW.US)$ to a hold rating.According to TipRanks data, the analyst has a success rate of 58.8% and a total average return of 16
Truist Financial Sticks to Its Hold Rating for Edwards Lifesciences (EW)
Express News | Edwards Lifesciences Corp : Truist Securities Cuts Target Price to $71 From $82
How Is Edwards Lifesciences' Stock Performance Compared to Other Medical Devices Stocks?
Three 'Buys,' Three 'Sells,' and a 'Hold,' by Oppenheimer Analysts
Edwards Lifesciences Price Target Maintained With a $90.00/Share by Oppenheimer
Oppenheimer Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $90
Oppenheimer analyst Suraj Kalia maintains $Edwards Lifesciences(EW.US)$ with a buy rating, and maintains the target price at $90.According to TipRanks data, the analyst has a success rate of 53.2%